Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
EUR | Fiscal Year Ending | | Latest |
(in millions) | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 2,255 | 2,317 | 2,568 | 2,836 | 3,098 | 829 | 838 | 2,363 | 3,002 | 3,061 | | 3,061 |
% Growth | NA | 2.8% | 10.9% | 10.4% | 9.2% | -73.2% | 1.1% | 181.9% | 27.0% | 2.0% | | |
| | | | | | | | | | | | |
Cost of Revenue | (1,915) | (1,888) | (1,975) | (2,238) | (2,494) | (971) | (1,017) | (2,255) | (2,464) | (2,621) | | (2,621) |
Gross Profit | 340 | 429 | 594 | 598 | 604 | (142) | (178) | 108 | 538 | 440 | | 440 |
% Revenue | 15.1% | 18.5% | 23.1% | 21.1% | 19.5% | -17.1% | -21.3% | 4.6% | 17.9% | 14.4% | | 14.4% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | (74) | (77) | (86) | (159) | (172) | (28) | (38) | (103) | (117) | (123) | | (123) |
General and Admin | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Inc / (Exp) | (156) | (244) | (284) | (232) | (265) | (419) | (279) | (270) | (199) | (180) | | (180) |
Total Operating Exp | (230) | (321) | (370) | (391) | (437) | (448) | (317) | (374) | (317) | (303) | | (303) |
| | | | | | | | | | | | |
Operating Income | 110 | 109 | 224 | 207 | 167 | (590) | (495) | (265) | 221 | 137 | | 137 |
% Revenue | 4.9% | 4.7% | 8.7% | 7.3% | 5.4% | -71.1% | -59.1% | -11.2% | 7.4% | 4.5% | | 4.5% |
| | | | | | | | | | | | |
Interest Expense | 3 | (3) | (13) | (80) | (74) | (65) | (87) | (105) | (102) | (91) | | (91) |
Pre-tax Income | 113 | 106 | 211 | 127 | 93 | (654) | (582) | (371) | 119 | 46 | | 46 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (24) | (21) | (42) | (26) | (18) | 131 | 118 | (105) | 135 | (9) | | (9) |
Net Income to Company | 90 | 85 | 169 | 102 | 75 | (523) | (464) | (476) | 254 | 37 | | 37 |
% Margin | 4.0% | 3.7% | 6.6% | 3.6% | 2.4% | -63.1% | -55.4% | -20.1% | 8.5% | 1.2% | | 1.2% |
| | | | | | | | | | | | |
Minority Interest in Earnings | (0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | 89 | 85 | 169 | 102 | 75 | (523) | (464) | (476) | 254 | 37 | | 37 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | (16) | (15) | (13) | (13) | (13) | (18) | (16) | (29) | (37) | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 73 | 70 | 157 | 89 | 62 | (541) | (481) | (505) | 217 | 37 | | 37 |
% Margin | 3.2% | 3.0% | 6.1% | 3.1% | 2.0% | -65.2% | -57.3% | -21.4% | 7.2% | 1.2% | | 1.2% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 57.20 | 55.07 | 123.00 | 69.59 | 48.55 | (51.40) | (34.19) | (35.92) | 2.25 | 0.18 | | 0.18 |
Diluted EPS (Continuing Ops) | 57.20 | 55.07 | 123.00 | 69.59 | 48.55 | (51.40) | (34.19) | (35.92) | 2.19 | 0.18 | | 0.18 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 1.28 | 1.27 | 1.27 | 1.28 | 1.28 | 10.52 | 14.06 | 14.07 | 96.40 | 204.50 | | 204.50 |
WA Diluted Shares Out. | 1.28 | 1.27 | 1.27 | 1.28 | 1.28 | 10.52 | 14.06 | 14.07 | 99.09 | 205.56 | | 205.56 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 113 | 106 | 211 | 127 | 93 | (654) | (582) | (371) | 119 | 46 | | 46 |
Addback: Net Interest Expense | (3) | 3 | 13 | 80 | 74 | 65 | 87 | 105 | 102 | 91 | | 91 |
Addback: Other Non Operating Expenses, Total | (10) | (37) | (11) | 50 | (6) | 128 | 40 | 69 | 8 | 15 | | 15 |
Addback: Depreciation & Amortization | 108 | 101 | 129 | 156 | 196 | 208 | 177 | 140 | 312 | 308 | | 308 |
Addback: Restructuring Charges | 3 | 1 | 1 | 0 | 3 | 0 | 0 | 35 | 14 | 1 | | 1 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | (1) | 1 | 4 | (0) | (3) | 0 | (4) | (38) | (37) | | (37) |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | (44) | (43) | (0) | (1) | (23) | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | 40 | 2 | 0 | 0 | 0 | 8 | 2 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | (154) | (33) | 0 | 0 | 0 | 0 | (20) | 0 | 0 | 0 | | 0 |
Adjusted EBITDA | 98 | 142 | 300 | 374 | 359 | (249) | (318) | (26) | 517 | 423 | | 423 |
% Margin | 4.4% | 6.1% | 11.7% | 13.2% | 11.6% | -30.1% | -38.0% | -1.1% | 17.2% | 13.8% | | 13.8% |
| | | | | | | | | | | | |
Adjusted EBIT | (10) | 42 | 170 | 218 | 163 | (457) | (495) | (165) | 205 | 115 | | 115 |
% Margin | -0.4% | 1.8% | 6.6% | 7.7% | 5.3% | -55.1% | -59.1% | -7.0% | 6.8% | 3.8% | | 3.8% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 90 | 85 | 169 | 102 | 75 | (523) | (464) | (476) | 254 | 37 | | 37 |
Addback: Unusual Items | (110) | (30) | (43) | (39) | 2 | 4 | (40) | 32 | (24) | (36) | | (36) |
Less: Tax Benefit of Unusual Items (26%) | 29 | 8 | 11 | 10 | (1) | (1) | 11 | (8) | 6 | 9 | | 9 |
Adjusted Net Income | 8 | 63 | 138 | 73 | 76 | (520) | (494) | (453) | 236 | 10 | | 10 |
% Margin | 0.4% | 2.7% | 5.4% | 2.6% | 2.5% | -62.7% | -58.9% | -19.2% | 7.9% | 0.3% | | 0.3% |